Steve Zhou Email and Phone Number

• Designed and directed over 2,000 virucidal efficacy, viral clearance, medical device 510(k), antiviral drug development, and cleaning and disinfection qualification studies for global regulatory submission• Appointed to a leadership role and reporting directly to the CEO of Microbac. Involved in budgeting and other financial analyses and decision-making• Serving as Test Facility Management and Facility Owner (FO) • Cross-functional operations of technical, customer service, business development, project management, and quality improvement • Working with Quality Assurance unit on audits and inspections• Expertise in GLP/cGMP/ISO and U.S. and international regulations• Extensive experience in assay validation• Assuring GLP/GMP/GCP/ISO17025 compliance of related studies • Writing and publishing papers/ technical articles; presenting at conferences• Decision maker for budgeting and other financial decisions• Train and develop direct reports and other staff members

• Directing viral clearance studies • Performing investigations in response to OOS and signing off on deviations• Virus and Cell banking; producing high-titered, purified viral stocks• Developing and validating new viral assays • Broad experience in classical Virology methods: TCID50, Plaque assays, etc. • Training and evaluating direct reports• Extensive GLP/cGMP and regulatory knowledge and experience

• Advisors: Gregory R. Reyes, M.D., Ph.D.; Bruce Malcolm, Ph.D.• Studied mechanisms of action of Ribavirin against Hepatitis C Virus (HCV)• Studied molecular mechanism of HCV NS5A and Interferon (IFN) response• High-throughput real-time RT-PCR assay using 384-well plates• High-throughput HCV NS5B polymerase assay• Experience in drug screening and drug-resistance• Co-owner of a patent on Ribavirin and IMPDH inhibitors